NCM
TIL icon

Nantahala Capital Management’s Instil Bio TIL Stock Holding History

Nantahala Capital Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,276
Closed -$1.36M – 147
2024
Q3 		$1.36M Sell
20,276
-107,016
-84% -$2.52M 0.07% 107
2024
Q2 		$1.31M Hold
127,292
– – 0.08% 100
2024
Q1 		$1.37M Hold
127,292
– – 0.08% 96
2023
Q4 		$970K Buy
127,292
+77,292
+155% +$559K 0.06% 106
2023
Q3 		$428K Buy
+50,000
New +$504K 0.04% 113

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Superstring Capital Management New York $158M AUM 418.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Nantahala Capital Management's TIL Position: Q4 2024 in Review

Nantahala Capital Management sold out of Instil Bio (TIL) in Q4 2024, closing a stake of 20,276 shares — an estimated $1.36M sold.

Nantahala Capital Management first reported a position in TIL in Q3 2023 and held it in 5 quarters. The position peaked at $1.37M in Q1 2024. 39 funds tracked by Wall St. Rank hold TIL as of Q4 2024.

  • Nantahala Capital Management reported no remaining Instil Bio position as of Q4 2024 after selling out during the quarter.
  • Nantahala Capital Management sold 20,276 Instil Bio shares in Q4 2024, an estimated $1.36M.
  • Nantahala Capital Management first reported a position in Instil Bio in Q3 2023 and held it in 5 quarters.
  • Nantahala Capital Management's Instil Bio position peaked at $1.37M in Q1 2024.
  • 39 funds tracked by Wall St. Rank held Instil Bio as of Q4 2024.

Based on Nantahala Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.